EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, Electrochemical, and Biological Evaluation of Fluorescent Chlorido[ N , N ′-bis(methoxy/hydroxy)salicylidene-1,2-bis(4-methoxyphenyl)ethylenediamine]iron(III) Complexes as Anticancer Agents

Astrid Dagmar Bernkop-Schnürch, Donja Chavooshi, Hubert Aaron Descher, Daniel Leitner, Heribert Talasz, Martin Hermann, Klaus Wurst, Stephan Hohloch iD, Ronald Gust iD, Brigitte Kircher iD

Journal of Medicinal Chemistry · 14.12.2023 · 66 (23) · 15916-15925

DOI: 10.1021/acs.jmedchem.3c01359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 28.11.2023. Verfasst von Astrid Dagmar Bernkop-Schnürch und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck, CCB─Center for Chemistry and Biomedic…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Iron. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The impact of methoxy and hydroxyl groups at the salicylidene moiety of chlorido[N,N'-bis(methoxy/hydroxy)salicylidene-1,2-bis(4-methoxyphenyl)ethylenediamine]iron(III) complexes was evaluated on human MDA-MB 231 breast cancer and HL-60 leukemia cells. Methoxylated complexes (C1-C3) inhibited proliferation, migration, and metabolic activity in a concentration-dependent manner following the rank order: C2 > C3 > C1. In particular, C2 was highly cytotoxic with an IC50 of 4.2 μM which was 6.6-fold lower than that of cisplatin (IC50 of 27.9 μM). In contrast, hydroxylated complexes C4-C6 were almost inactive up to the highest concentration tested due to lack of cellular uptake. C2 caused a dual mode of cell death, ferroptosis, and necroptosis, whereby at higher concentrations, ferroptosis was the preferred form. Ferroptotic morphology and the presence of ferrous iron and lipid reactive oxygen species proved the involvement of ferroptosis. C2 was identified as a promising lead compound for the design of drug candidates inducing ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsIronHumansCell DeathCell Line, TumorEthylenediaminesCoordination Complexes

Substanzen

Antineoplastic AgentsEthylenediaminesIronCoordination Complexes

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck, CCB─Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria.
  • Immunobiology and Stem Cell Laboratory, Department of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria.
  • Department of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria.
  • Biocenter, Institute of Medical Biochemistry, Protein Core Facility, Medical University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria.
  • Department of Anesthesiology and Critical Care Medicine, Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria.
  • Tyrolean Cancer Research Institute, Innrain 66, 6020 Innsbruck, Austria.

ORCID-Profile: Stephan Hohloch, Ronald Gust, Brigitte Kircher

Förderung

  • Austrian Science Fund

Zitieren

APA

Bernkop-Schnürch, A. D., Chavooshi, D., Descher, H. A., Leitner, D., Talasz, H., Hermann, M., Wurst, K., Hohloch, S., Gust, R., & Kircher, B. (2023). Design, Synthesis, Electrochemical, and Biological Evaluation of Fluorescent Chlorido[ N , N ′-bis(methoxy/hydroxy)salicylidene-1,2-bis(4-methoxyphenyl)ethylenediamine]iron(III) Complexes as Anticancer Agents. Journal of Medicinal Chemistry, 66(23), 15916-15925. https://doi.org/10.1021/acs.jmedchem.3c01359

Vancouver

Bernkop-Schnürch AD, Chavooshi D, Descher HA, Leitner D, Talasz H, Hermann M, et al. Design, Synthesis, Electrochemical, and Biological Evaluation of Fluorescent Chlorido[ N , N ′-bis(methoxy/hydroxy)salicylidene-1,2-bis(4-methoxyphenyl)ethylenediamine]iron(III) Complexes as Anticancer Agents. Journal of Medicinal Chemistry. 2023;66(23):15916-15925. doi:10.1021/acs.jmedchem.3c01359

BibTeX
@article{BernkopSchnrch2023,
  author = {Bernkop-Schnürch, Astrid Dagmar and Chavooshi, Donja and Descher, Hubert Aaron and Leitner, Daniel and Talasz, Heribert and Hermann, Martin and Wurst, Klaus and Hohloch, Stephan and Gust, Ronald and Kircher, Brigitte},
  title = {Design, Synthesis, Electrochemical, and Biological Evaluation of Fluorescent Chlorido[ N , N ′-bis(methoxy/hydroxy)salicylidene-1,2-bis(4-methoxyphenyl)ethylenediamine]iron(III) Complexes as Anticancer Agents},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {23},
  pages = {15916--15925},
  doi = {10.1021/acs.jmedchem.3c01359}
}
Kostenlos starten →